Identification of Biomarkers Associated with Heart Failure Caused by Idiopathic Dilated Cardiomyopathy Using WGCNA and Machine Learning Algorithms
Source check: Source checked. Not independent scientific confirmation.
Finding: WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data. AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.
Technology: Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Weighted gene co-expression network analysis (WGCNA) narrowed candidate genes; SVM-RFE and LASSO selected biomarkers, then external GEO expression datasets checked AQP3 and CYP2J2.
- Test and result
- WGCNA, SVM-RFE and LASSO identified 13 candidate genes from idiopathic-dilated-cardiomyopathy heart-failure expression data
- Limitation / still unknown
- AQP3 and CYP2J2 showed diagnostic signal in GEO datasets GSE57338 and GSE6406, respectively; this is retrospective transcriptomic analysis, not clinical validation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10154102/ · https://pubmed.ncbi.nlm.nih.gov/37143707/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.